HSP27 inhibitor attenuates radiation-induced pulmonary inflammation

Jee Youn Kim, Yong Min An, Byeong Rok Yoo, Jin Mo Kim, Song Yee Han, Younghwa Na, Yun Sil Lee, Jaeho Cho

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Radiation therapy has been used to treat over 70% of thoracic cancer; however, the method usually causes radiation pneumonitis. In the current study, we investigated the radioprotective effects of HSP27 inhibitor (J2) on radiation-induced lung inflammation in comparison to amifostine. In gross and histological findings, J2 treatment significantly inhibited immune cell infiltration in lung tissue, revealing anti-inflammatory potential of J2. Normal lung volume, evaluated by micro-CT analysis, in J2-treated mice was higher compared to that in irradiated mice. J2-treated mice reversed radiation-induced respiratory distress. However, amifostine did not show significant radioprotective effects in comparison to that of J2. In HSP27 transgenic mice, we observed increased immune cells recruitment and decreased volume of normal lung compared to wild type mice. Increased ROS production and oxidative stress after IR were down-regulated by J2 treatment, demonstrating antioxidant property of J2. The entire data of this study collectively showed that J2 may be an effective therapeutic agent for radiation-induced lung injury.

Original languageEnglish
Article number4189
JournalScientific reports
Volume8
Issue number1
DOIs
Publication statusPublished - 2018 Dec 1

Fingerprint

Pneumonia
Amifostine
Radiation
Lung
Radiation Pneumonitis
Lung Injury
Transgenic Mice
Oxidative Stress
Anti-Inflammatory Agents
Radiotherapy
Thorax
Therapeutics
Antioxidants
Neoplasms

All Science Journal Classification (ASJC) codes

  • General

Cite this

Kim, Jee Youn ; An, Yong Min ; Yoo, Byeong Rok ; Kim, Jin Mo ; Han, Song Yee ; Na, Younghwa ; Lee, Yun Sil ; Cho, Jaeho. / HSP27 inhibitor attenuates radiation-induced pulmonary inflammation. In: Scientific reports. 2018 ; Vol. 8, No. 1.
@article{8be95684de3647a58210527f046548f5,
title = "HSP27 inhibitor attenuates radiation-induced pulmonary inflammation",
abstract = "Radiation therapy has been used to treat over 70{\%} of thoracic cancer; however, the method usually causes radiation pneumonitis. In the current study, we investigated the radioprotective effects of HSP27 inhibitor (J2) on radiation-induced lung inflammation in comparison to amifostine. In gross and histological findings, J2 treatment significantly inhibited immune cell infiltration in lung tissue, revealing anti-inflammatory potential of J2. Normal lung volume, evaluated by micro-CT analysis, in J2-treated mice was higher compared to that in irradiated mice. J2-treated mice reversed radiation-induced respiratory distress. However, amifostine did not show significant radioprotective effects in comparison to that of J2. In HSP27 transgenic mice, we observed increased immune cells recruitment and decreased volume of normal lung compared to wild type mice. Increased ROS production and oxidative stress after IR were down-regulated by J2 treatment, demonstrating antioxidant property of J2. The entire data of this study collectively showed that J2 may be an effective therapeutic agent for radiation-induced lung injury.",
author = "Kim, {Jee Youn} and An, {Yong Min} and Yoo, {Byeong Rok} and Kim, {Jin Mo} and Han, {Song Yee} and Younghwa Na and Lee, {Yun Sil} and Jaeho Cho",
year = "2018",
month = "12",
day = "1",
doi = "10.1038/s41598-018-22635-9",
language = "English",
volume = "8",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

Kim, JY, An, YM, Yoo, BR, Kim, JM, Han, SY, Na, Y, Lee, YS & Cho, J 2018, 'HSP27 inhibitor attenuates radiation-induced pulmonary inflammation', Scientific reports, vol. 8, no. 1, 4189. https://doi.org/10.1038/s41598-018-22635-9

HSP27 inhibitor attenuates radiation-induced pulmonary inflammation. / Kim, Jee Youn; An, Yong Min; Yoo, Byeong Rok; Kim, Jin Mo; Han, Song Yee; Na, Younghwa; Lee, Yun Sil; Cho, Jaeho.

In: Scientific reports, Vol. 8, No. 1, 4189, 01.12.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - HSP27 inhibitor attenuates radiation-induced pulmonary inflammation

AU - Kim, Jee Youn

AU - An, Yong Min

AU - Yoo, Byeong Rok

AU - Kim, Jin Mo

AU - Han, Song Yee

AU - Na, Younghwa

AU - Lee, Yun Sil

AU - Cho, Jaeho

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Radiation therapy has been used to treat over 70% of thoracic cancer; however, the method usually causes radiation pneumonitis. In the current study, we investigated the radioprotective effects of HSP27 inhibitor (J2) on radiation-induced lung inflammation in comparison to amifostine. In gross and histological findings, J2 treatment significantly inhibited immune cell infiltration in lung tissue, revealing anti-inflammatory potential of J2. Normal lung volume, evaluated by micro-CT analysis, in J2-treated mice was higher compared to that in irradiated mice. J2-treated mice reversed radiation-induced respiratory distress. However, amifostine did not show significant radioprotective effects in comparison to that of J2. In HSP27 transgenic mice, we observed increased immune cells recruitment and decreased volume of normal lung compared to wild type mice. Increased ROS production and oxidative stress after IR were down-regulated by J2 treatment, demonstrating antioxidant property of J2. The entire data of this study collectively showed that J2 may be an effective therapeutic agent for radiation-induced lung injury.

AB - Radiation therapy has been used to treat over 70% of thoracic cancer; however, the method usually causes radiation pneumonitis. In the current study, we investigated the radioprotective effects of HSP27 inhibitor (J2) on radiation-induced lung inflammation in comparison to amifostine. In gross and histological findings, J2 treatment significantly inhibited immune cell infiltration in lung tissue, revealing anti-inflammatory potential of J2. Normal lung volume, evaluated by micro-CT analysis, in J2-treated mice was higher compared to that in irradiated mice. J2-treated mice reversed radiation-induced respiratory distress. However, amifostine did not show significant radioprotective effects in comparison to that of J2. In HSP27 transgenic mice, we observed increased immune cells recruitment and decreased volume of normal lung compared to wild type mice. Increased ROS production and oxidative stress after IR were down-regulated by J2 treatment, demonstrating antioxidant property of J2. The entire data of this study collectively showed that J2 may be an effective therapeutic agent for radiation-induced lung injury.

UR - http://www.scopus.com/inward/record.url?scp=85048260153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048260153&partnerID=8YFLogxK

U2 - 10.1038/s41598-018-22635-9

DO - 10.1038/s41598-018-22635-9

M3 - Article

C2 - 29520071

AN - SCOPUS:85048260153

VL - 8

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 4189

ER -